Cargando…
Telmisartan inhibits hepatocellular carcinoma cell proliferation in vitro by inducing cell cycle arrest
Hepatocellular carcinoma (HCC) is the most common primary malignancy of the liver and the third leading cause of cancer-related death. Telmisartan, a widely used antihypertensive drug, is an angiotensin II type 1 (AT1) receptor blocker (ARB) that might inhibit cancer cell proliferation, but the mech...
Autores principales: | Oura, Kyoko, Tadokoro, Tomoko, Fujihara, Shintaro, Morishita, Asahiro, Chiyo, Taiga, Samukawa, Eri, Yamana, Yoshimi, Fujita, Koji, Sakamoto, Teppei, Nomura, Takako, Yoneyama, Hirohito, Kobara, Hideki, Mori, Hirohito, Iwama, Hisakazu, Okano, Keiichi, Suzuki, Yasuyuki, Masaki, Tsutomu |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5780034/ https://www.ncbi.nlm.nih.gov/pubmed/29048654 http://dx.doi.org/10.3892/or.2017.5977 |
Ejemplares similares
-
Angiotensin receptor blocker telmisartan inhibits cell proliferation and tumor growth of cholangiocarcinoma through cell cycle arrest
por: Samukawa, Eri, et al.
Publicado: (2017) -
The angiotensin II type 1 receptor antagonist telmisartan inhibits cell proliferation and tumor growth of esophageal adenocarcinoma via the AMPKa/mTOR pathway in vitro and in vivo
por: Fujihara, Shintaro, et al.
Publicado: (2016) -
Cancer Therapy Due to Apoptosis: Galectin-9
por: Fujita, Koji, et al.
Publicado: (2017) -
Galectin-9 ameliorates fulminant liver injury
por: Tadokoro, Tomoko, et al.
Publicado: (2017) -
Telmisartan Inhibits Cell Proliferation and Tumor Growth of Esophageal Squamous Cell Carcinoma by Inducing S-Phase Arrest In Vitro and In Vivo
por: Matsui, Takanori, et al.
Publicado: (2019)